Works matching AU Szarek, Michael

Results: 45

Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203

By:

Cherney, David Z. I.;
Bhatt, Deepak L.;
Szarek, Michael;
Sun, Franklin;
Girard, Manon;
Davies, Michael J.;
Pitt, Bertram;
Steg, Ph. Gabriel

Publication type:

Article

Is it time to get SIRIUS about in silico modelling of cardiovascular outcomes trials?

Published in:

European Journal of Preventive Cardiology, 2024, v. 31, n. 15, p. 1831, doi. 10.1093/eurjpc/zwae329

By:

Bonaca, Marc P;
Szarek, Michael;
Schwartz, Gregory G

Publication type:

Article

Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.

Published in:

European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110

By:

Szarek, Michael;
Reijnders, Esther;
Steg, Ph Gabriel;
Jukema, J Wouter;
Schwertfeger, Markus;
Bhatt, Deepak L;
Bittner, Vera A;
Diaz, Rafael;
Fazio, Sergio;
Garon, Genevieve;
Goodman, Shaun G;
Harrington, Robert A;
White, Harvey D;
Zeiher, Andreas M;
Cobbaert, Christa;
Schwartz, Gregory G

Publication type:

Article

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab.

Published in:

European Journal of Preventive Cardiology, 2022, v. 29, n. 14, p. 1842, doi. 10.1093/eurjpc/zwac107

By:

Landmesser, Ulf;
McGinniss, Jennifer;
Steg, Ph Gabriel;
Bhatt, Deepak L;
Bittner, Vera A;
Diaz, Rafael;
Dilic, Mirza;
Goodman, Shaun G;
Jukema, J Wouter;
Loy, Megan;
Pećin, Ivan;
Pordy, Robert;
Poulsen, Steen H;
Szarek, Michael;
White, Harvey D;
Schwartz, Gregory G

Publication type:

Article

Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.

Published in:

European Journal of Preventive Cardiology, 2022, v. 29, n. 5, p. e181, doi. 10.1093/eurjpc/zwab128

By:

Anand, Sonia S;
Hiatt, Will;
Dyal, Leanne;
Bauersachs, Rupert;
Berkowitz, Scott D;
Branch, Kelley R H;
Debus, Sebastian;
Fox, Keith A A;
Liang, Yan;
Muehlhofer, Eva;
Nehler, Mark;
Haskell, Lloyd P;
Patel, Manesh;
Szarek, Michael;
Yusuf, Salim;
Eikelboom, John;
Bonaca, Marc P

Publication type:

Article

Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.

Published in:

European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987

By:

Diaz, Rafael;
Li, Qian H.;
Bhatt, Deepak L.;
Bittner, Vera A.;
Baccara-Dinet, Marie T.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Takeshi Kimura;
Parkhomenko, Alexander;
Pordy, Robert;
Reiner;, Željko;
Roe, Matthew T.;
Szarek, Michael;
Hung-Fat Tse;
White, Harvey D.;
Zahger, Doron;
Zeiher, Andreas M.;
Schwartz, Gregory G.;
Steg, Ph Gabriel

Publication type:

Article

Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.

Published in:

European Journal of Preventive Cardiology, 2017, v. 24, n. 12, p. 1294, doi. 10.1177/2047487317708677

By:

Schwartz, Gregory G;
Fayyad, Rana;
Szarek, Michael;
DeMicco, David;
Olsson, Anders G

Publication type:

Article

Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.

Published in:

2021

By:

Szarek, Michael;
Bhatt, Deepak L.;
Steg, Ph. Gabriel;
Cannon, Christopher P.;
Leiter, Lawrence A.;
McGuire, Darren K.;
Lewis, Julia B.;
Riddle, Matthew C.;
Voors, Adriaan A.;
Metra, Marco;
Lund, Lars H.;
Komajda, Michel;
Testani, Jeffrey M.;
Wilcox, Christopher S.;
Ponikowski, Piotr;
Lopes, Renato D.;
Banks, Phillip;
Tesfaye, Eshetu;
Ezekowitz, Justin A.;
Verma, Subodh

Publication type:

journal article

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.

Published in:

JAMA Network Open, 2022, v. 5, n. 6, p. e2215580, doi. 10.1001/jamanetworkopen.2022.15580

By:

Hess, Connie N.;
Szarek, Michael;
Anand, Sonia S.;
Bauersachs, Rupert M.;
Patel, Manesh R.;
Debus, E. Sebastian;
Nehler, Mark R.;
Capell, Warren H.;
Beckman, Joshua A.;
Piazza, Gregory;
Henkin, Stanislav;
Bura-Rivière, Alessandra;
Lawall, Holger;
Roztocil, Karel;
Hsia, Judith;
Muehlhofer, Eva;
Berkowitz, Scott D.;
Haskell, Lloyd P.;
Bonaca, Marc P.

Publication type:

Article

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial.

Published in:

Diabetes Care, 2025, v. 48, n. 4, p. 596, doi. 10.2337/dc24-2110

By:

Schwartz, Gregory G.;
Szarek, Michael;
Jukema, J. Wouter;
Cobbaert, Christa M.;
Reijnders, Esther;
Bittner, Vera A.;
Schwertfeger, Markus;
Bhatt, Deepak L.;
Fazio, Sergio;
Garon, Genevieve;
Goodman, Shaun G.;
Harrington, Robert A.;
White, Harvey D.;
Steg, Philippe Gabriel

Publication type:

Article

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Published in:

2021

By:

Schwartz, Gregory G.;
Szarek, Michael;
Bittner, Vera A.;
Bhatt, Deepak L.;
Diaz, Rafael;
Goodman, Shaun G.;
Jukema, J. Wouter;
Loy, Megan;
Manvelian, Garen;
Pordy, Robert;
White, Harvey D.;
Steg, Philippe Gabriel;
Harrington, Robert A.;
Zeiher, Andreas M.;
Tricoci, Pierluigi;
Roe, Matthew T.;
Mahaffey, Kenneth W.;
Edelberg, Jay M.;
Hanotin, Corinne;
Lecorps, Guillaume

Publication type:

journal article

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial.

Published in:

JAMA: Journal of the American Medical Association, 2005, v. 294, n. 19, p. 2437, doi. 10.1001/jama.294.19.2437

By:

Pedersen, Terje R.;
Faergeman, Ole;
Kastelein, John J. P.;
Olsson, Anders G.;
Tikkanen, Matti J.;
Holme, Ingar;
Larsen, Mogens Lytken;
Bendiksen, Fredrik S.;
Lindahl, Christina;
Szarek, Michael;
Tsai, John

Publication type:

Article

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

Published in:

European Heart Journal, 2005, v. 26, n. 9, p. 890, doi. 10.1093/eurheartj/ehi186

By:

Olsson, Anders G.;
Schwartz, Gregory G.;
Szarek, Michael;
Sasiela, William J.;
Ezekowitz, Michael D.;
Ganz, Peter;
Oliver, Michael F.;
Waters, David;
Zeiher, Andreas

Publication type:

Article

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.

Published in:

2005

By:

Schwartz GG;
Olsson AG;
Szarek M;
Sasiela WJ;
Schwartz, Gregory G;
Olsson, Anders G;
Szarek, Michael;
Sasiela, William J

Publication type:

journal article

Relation of Characteristics of Metabolic Syndrome to Short-Term Prognosis and Effects of Intensive Statin Therapy After Acute Coronary Syndrome.

Published in:

Diabetes Care, 2005, v. 28, n. 10, p. 2508, doi. 10.2337/diacare.28.10.2508

By:

Schwartz, Gregory G.;
Olsson, Anders G.;
Szarek, Michael;
Sasiela, William J.

Publication type:

Article

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Published in:

Diabetes & Vascular Disease Research, 2008, v. 5, n. 3, p. 177, doi. 10.3132/dvdr.2008.029

By:

Newman, Connie B;
Szarek, Michael;
Colhoun, Helen M;
Betteridge, D John;
Durrington, Paul N;
Hitman, Graham A;
Neil, H Andrew W;
Demicco, David A;
Auster, Sheila;
Fuller, John H

Publication type:

Article

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

2023

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph.Gabriel

Publication type:

Correction Notice

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Factors Related to the Sensitivity of Emergency Medical Service Impression of Stroke.

Published in:

Prehospital Emergency Care, 2014, v. 18, n. 3, p. 387, doi. 10.3109/10903127.2013.864359

By:

Gropen, Toby I.;
Gokaldas, Reshma;
Poleshuck, Rebecca;
Spencer, Jeffrey;
Janjua, Nazli;
Szarek, Michael;
Brandler, Ethan S.;
Levine, Steven R.

Publication type:

Article

Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.

Published in:

Journal of the American Heart Association, 2025, v. 14, n. 5, p. 1, doi. 10.1161/JAHA.124.038656

By:

Aggarwal, Rahul;
Bhatt, Deepak L.;
Steg, Gabriel;
Miller, Michael;
Brinton, Eliot A.;
Dunbar, Richard L.;
Ketchum, Steven B.;
Tardif, Jean-Claude;
Martens, Fabrice M. A. C.;
Ballantyne, Christie M.;
Szarek, Michael;
Mason, R. Preston

Publication type:

Article

Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.

Published in:

Journal of the American Heart Association, 2024, v. 13, n. 8, p. 1, doi. 10.1161/JAHA.123.032782

By:

Zhong Yuan;
Levitan, Bennett;
Hsiaowei Deng;
Szarek, Michael;
Bauersachs, Rupert M.;
Berkowitz, Scott D.;
Haskell, Lloyd;
Barnathan, Elliot S.;
Bonaca, Marc P.

Publication type:

Article

Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Tria.

Published in:

Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.122.029216

By:

Goodman, Shaun G.;
Steg, Philippe Gabriel;
Poulouin, Yann;
Bhatt, Deepak L.;
Bittner, Vera A.;
Diaz, Rafael;
Garon, Genevieve;
Harrington, Robert A.;
Jukema, J. Wouter;
Manvelian, Garen;
Stipek, Wanda;
Szarek, Michael;
White, Harvey D.;
Schwartz, Gregory G.

Publication type:

Article

Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.

Published in:

2022

By:

Hess, Connie N.;
Baumgartner, Iris;
Anand, Sonia S.;
Nehler, Mark R.;
Patel, Manesh R.;
Debus, E. Sebastian;
Szarek, Michael;
Capell, Warren;
Muehlhofer, Eva;
Berkowitz, Scott D.;
Haskell, Lloyd P.;
Bauersachs, Rupert M.;
Bonaca, Marc P.;
Hsia, Judith

Publication type:

journal article

Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.

Published in:

2022

By:

Szarek, Michael;
Hess, Connie;
Patel, Manesh R.;
Jones, W. Schuyler;
Berger, Jeffrey S.;
Baumgartner, Iris;
Katona, Brian;
Mahaffey, Kenneth W.;
Norgren, Lars;
Blomster, Juuso;
Rockhold, Frank W.;
Hsia, Judith;
Fowkes, F. Gerry R.;
Bonaca, Marc P.

Publication type:

journal article

Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: A potential marker of response to immunotherapy?

Published in:

International Journal of Cancer, 2006, v. 119, n. 1, p. 157, doi. 10.1002/ijc.21820

By:

Reynolds, Sandra R.;
Vergilis, Irene J.;
Szarek, Michael;
Ferrone, Soldano;
Bystryn, Jean-Claude

Publication type:

Article

Estimation of overall survival in an 'illness-death' model with application to the vertical transmission of HIV-1.

Published in:

Statistics in Medicine, 2010, v. 29, n. 19, p. 2045, doi. 10.1002/sim.3949

By:

Frydman, Halina;
Szarek, Michael

Publication type:

Article

Presence and Prognostic Significance of Melanoma-Associated Antigens CYT-MAA and HMW-MAA in Serum of Patients with Melanoma.

Published in:

Journal of Investigative Dermatology, 2005, v. 125, n. 3, p. 526, doi. 10.1111/j.0022-202X.2005.23798.x

By:

Vergilis, Irene J.;
Szarek, Michael;
Ferrone, Soldano;
Reynolds, Sandra R.

Publication type:

Article

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.

Published in:

Cancer Medicine, 2023, v. 12, n. 16, p. 16859, doi. 10.1002/cam4.6310

By:

Mohammadi, Kusha A.;
Brackin, Taylor;
Schwartz, Gregory G.;
Steg, Philippe Gabriel;
Szarek, Michael;
Manvelian, Garen;
Pordy, Robert;
Fazio, Sergio;
Geba, Gregory P.

Publication type:

Article

Atorvastatin Reduces the Risk of Major Cardiovascular Events in Patients With Diabetes and Impaired Renal Function in the Collaborative Atorvastatin Diabetes Study (CARDS).

Published in:

Diabetes, 2007, v. 56, p. A139

By:

Colhoun, Helen M.;
Szarek, Michael;
Demicco, David A.;
Nell, Andrew W.;
Betteridge, John;
Hitman, Graham A.;
Durrington, Paul N.;
Fuller, John H.

Publication type:

Article

Risk of Stroke and Cardiovascular Events in Patients with Type 2 Diabetes or Metabolic Syndrome in the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial.

Published in:

Diabetes, 2007, v. 56, p. A69

By:

Callahan, Alfred;
Welch, K. M.;
Amarenco, Pierre;
Szarek, Michael;
Rudolph, Amy E.;
Goldstein, Larry B.;
Hennerici, Michael;
Sillesen, Henrik;
Zivin, Justin A.

Publication type:

Article

The Correlation between Global Health Experiences in Low-Income Countries on Choice of Primary Care Residencies for Graduates of an Urban US Medical School.

Published in:

Journal of Urban Health, 2014, v. 91, n. 2, p. 394, doi. 10.1007/s11524-013-9829-4

By:

Bruno, Denise;
Imperato, Pascal;
Szarek, Michael

Publication type:

Article

Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.

Published in:

JAMA: Journal of the American Medical Association, 2024, v. 332, n. 23, p. 1992, doi. 10.1001/jama.2024.21957

By:

Nissen, Steven E.;
Wang, Qiuqing;
Nicholls, Stephen J.;
Navar, Ann Marie;
Ray, Kausik K.;
Schwartz, Gregory G.;
Szarek, Michael;
Stroes, Erik S. G.;
Troquay, Roland;
Dorresteijn, Jannick A. N.;
Fok, Henry;
Rider, David A.;
Romano, Steven;
Wolski, Kathy;
Rambaran, Curtis

Publication type:

Article

Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial.

Published in:

2025

By:

Hess, Connie N;
Daffron, Ashley;
Nehler, Mark R;
Szarek, Michael;
Cannon, Christopher P;
Hsia, Judith;
Saseen, Joseph J;
Bonaca, Marc P

Publication type:

Letter

Nonparametric Estimation in a Markov “Illness–Death” Process from Interval Censored Observations with Missing Intermediate Transition Status.

Published in:

Biometrics, 2009, v. 65, n. 1, p. 143, doi. 10.1111/j.1541-0420.2008.01056.x

By:

Frydman, Halina;
Szarek, Michael

Publication type:

Article

Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial.

Published in:

European Journal of Heart Failure, 2024, v. 26, n. 4, p. 1093, doi. 10.1002/ejhf.3240

By:

Aggarwal, Rahul;
Bhatt, Deepak L.;
Szarek, Michael;
Leiter, Lawrence A.;
Cannon, Christopher P.;
Lopes, Renato D.;
Davies, Michael J;
Banks, Phillip;
Pitt, Bertram;
Steg, Ph. Gabriel

Publication type:

Article

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144

By:

Schwartz, Gregory G;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Bujas-Bobanovic, Maja;
Diaz, Rafael;
Fazio, Sergio;
Fras, Zlatko;
Goodman, Shaun G;
Harrington, Robert A;
Jukema, J Wouter;
Manvelian, Garen;
Pordy, Robert;
Ray, Kausik K;
Scemama, Michel;
White, Harvey D;
Steg, Ph Gabriel;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Alirocumab after acute coronary syndrome in patients with a history of heart failure.

Published in:

European Heart Journal, 2022, v. 43, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab804

By:

White, Harvey D;
Schwartz, Gregory G;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Chiang, Chern-En;
Diaz, Rafael;
Goodman, Shaun G;
Jukema, Johan Wouter;
Loy, Megan;
Pagidipati, Neha;
Pordy, Robert;
Ristić, Arsen D;
Zeiher, Andreas M;
Wojdyla, Daniel M;
Steg, Philippe Gabriel;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.

Published in:

European Heart Journal, 2021, v. 42, n. 39, p. 4040, doi. 10.1093/eurheartj/ehab408

By:

Krantz, Mori J;
Debus, Sebastian E;
Hsia, Judith;
Patel, Manesh R;
Anand, Sonia S;
Nehler, Mark R;
Hess, Connie N;
Capell, Warren H;
Bracken, Taylor;
Szarek, Michael;
Mátyás, Lajos;
Krievins, Dainis K;
Nault, Patrice;
Stefanov, Stefan;
Haskell, Lloyd P;
Berkowitz, Scott D;
Muehlhofer, Eva;
Hiatt, William R;
Bauersachs, Rupert M;
Bonaca, Marc P

Publication type:

Article

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2020, v. 41, n. 44, p. 4245, doi. 10.1093/eurheartj/ehaa649

By:

Szarek, Michael;
Bittner, Vera A;
Aylward, Philip;
Baccara-Dinet, Marie;
Bhatt, Deepak L;
Diaz, Rafael;
Fras, Zlatko;
Goodman, Shaun G;
Halvorsen, Sigrun;
Harrington, Robert A;
Jukema, J Wouter;
Moriarty, Patrick M;
Pordy, Robert;
Ray, Kausik K;
Sinnaeve, Peter;
Tsimikas, Sotirios;
Vogel, Robert;
White, Harvey D;
Zahger, Doron;
Zeiher, Andreas M

Publication type:

Article

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.

Published in:

European Heart Journal, 2020, v. 41, n. 42, p. 4114, doi. 10.1093/eurheartj/ehaa498

By:

Tuñón, José;
Steg, Philippe Gabriel;
Bhatt, Deepak L;
Bittner, Vera A;
Díaz, Rafael;
Goodman, Shaun G;
Jukema, J Wouter;
Kim, Yong-Un;
Li, Qian H;
Mueller, Christian;
Parkhomenko, Alexander;
Pordy, Robert;
Sritara, Piyamitr;
Szarek, Michael;
White, Harvey D;
Zeiher, Andreas M;
Schwartz, Gregory G;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Published in:

European Heart Journal, 2020, v. 41, n. 24, p. 2248, doi. 10.1093/eurheartj/ehz809

By:

Sinnaeve, Peter R;
Schwartz, Gregory G;
Wojdyla, Daniel M;
Alings, Marco;
Bhatt, Deepak L;
Bittner, Vera A;
Chiang, Chern-En;
Flores, Roger M Correa;
Diaz, Rafael;
Dorobantu, Maria;
Goodman, Shaun G;
Jukema, J Wouter;
Kim, Yong-Un;
Pordy, Robert;
Roe, Matthew T;
Sy, Rody G;
Szarek, Michael;
White, Harvey D;
Zeiher, Andreas M;
Steg, Ph Gabriel

Publication type:

Article

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2019, v. 40, n. 33, p. 2801, doi. 10.1093/eurheartj/ehz299

By:

White, Harvey D;
Steg, Ph Gabriel;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Diaz, Rafael;
Edelberg, Jay M;
Erglis, Andrejs;
Goodman, Shaun G;
Hanotin, Corinne;
Harrington, Robert A;
Jukema, J Wouter;
Lopes, Renato D;
Mahaffey, Kenneth W;
Moryusef, Angele;
Pordy, Robert;
Roe, Matthew T;
Sritara, Piyamitr;
Tricoci, Pierluigi;
Zeiher, Andreas M

Publication type:

Article

Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.

Published in:

Clinical Cardiology, 2022, v. 45, n. 12, p. 1143, doi. 10.1002/clc.23926

By:

Bonaca, Marc P.;
Szarek, Michael;
Debus, E. Sebastian;
Nehler, Mark R.;
Patel, Manesh R.;
Anand, Sonia S.;
Muehlhofer, Eva;
Berkowitz, Scott D.;
Haskell, Lloyd P.;
Bauersachs, Rupert M.

Publication type:

Article

Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.

Published in:

Clinical Genitourinary Cancer, 2021, v. 19, n. 5, p. 468.e1, doi. 10.1016/j.clgc.2021.03.018

By:

Szarek, Michael;
Needle, Michael N.;
Rini, Brian I.;
Pal, Sumanta K.;
McDermott, David F.;
Atkins, Michael B.;
Hutson, Thomas E.;
Escudier, Bernard J.

Publication type:

Article